Rigel Pharmaceuticals Inc. (New) (RIGL) is a publicly traded Healthcare sector company. As of July 26, 2026, RIGL trades at $36.74 with a market cap of $679.77M and a P/E ratio of 1.81. RIGL moved -0.11% today. Year to date, RIGL is -14.22%; over the trailing twelve months it is +79.83%. Its 52-week range spans $14.63 to $52.24. Analyst consensus is buy with an average price target of $59.33. Rallies surfaces RIGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for RIGL, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $36.74 |
| Market Cap | $679.77M |
| P/E Ratio | 1.81 |
| EPS | $20.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $52.24 |
| 52-Week Low | $14.63 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $299.77M |
| Net Income | $364.23M |
| Gross Margin | 93.39% |
3 analysts cover RIGL: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $59.33.